ARTICLE | Clinical News
Velcade bortezomib: Phase II started
February 25, 2008 8:00 AM UTC
Millennium began an open-label Phase II trial to evaluate Velcade in combination with Treanda bendamustine and Rituxan rituximab in about 75 patients with relapsed follicular lymphoma. Millennium an...